Brian DeSchuytner

2022

In 2022, Brian DeSchuytner earned a total compensation of $1.3M as Senior Vice President, Chief Financial Officer at Mersana Therapeutics, a 53% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$198,012
Option Awards$514,170
Salary$421,303
Stock Awards$157,000
Other$7,000
Total$1,297,485

DeSchuytner received $514.2K in option awards, accounting for 40% of the total pay in 2022.

DeSchuytner also received $198K in non-equity incentive plan, $421.3K in salary, $157K in stock awards and $7K in other compensation.

Rankings

In 2022, Brian DeSchuytner's compensation ranked 2,526th out of 5,753 executives tracked by ExecPay. In other words, DeSchuytner earned more than 56.1% of executives.

ClassificationRankingPercentile
All
2,526
out of 5,753
56th
Division
Manufacturing
1,393
out of 3,133
56th
Major group
Chemicals And Allied Products
631
out of 1,419
56th
Industry group
Drugs
585
out of 1,320
56th
Industry
Pharmaceutical Preparations
419
out of 966
57th

Pay ratio

Brian DeSchuytner's Pay$1,297,485
Median Employee's Pay$243,051
Pay Ratio

5

to 1

In 2022, the annual total compensation of Brian DeSchuytner was $1,297,485.

The annual total compensation of the median employee at Mersana Therapeutics was $243,051.

The ratio of Brian DeSchuytner's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 28, 2023.

DeSchuytner's colleagues

We found four more compensation records of executives who worked with Brian DeSchuytner at Mersana Therapeutics in 2022.

2022

Anna Protopapas

Mersana Therapeutics

Chief Executive Officer

2022

Arvin Yang

Mersana Therapeutics

Chief Medical Officer

2022

Timothy Lowinger

Mersana Therapeutics

Chief Science and Technology Officer

2022

Alejandra Carvajal

Mersana Therapeutics

Chief Legal Officer

News

You may also like